What is DNASTAR?
DNASTAR is a leading provider of bioinformatics software solutions tailored for life science researchers. Their comprehensive suite of tools facilitates critical analyses in areas such as sequence analysis, molecular biology, genomics, and protein modeling. The company's flagship product, Lasergene, is widely recognized for its accuracy, versatility, and intuitive design, making it a staple in research institutions globally. Beyond software, DNASTAR also offers specialized genomic and protein analysis services, further supporting researchers in advancing their projects. The company's commitment to innovation drives the continuous development of advanced applications designed to optimize and streamline complex bioinformatics workflows.
How much funding has DNASTAR raised?
DNASTAR has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in DNASTAR
PPP
Public-Private Partnership
What's next for DNASTAR?
With its recent strategic investment and substantial total funding, DNASTAR is well-positioned for its next phase of expansion. The company's focus on developing cutting-edge bioinformatics tools and services suggests a strategic direction towards enhancing its market leadership and potentially exploring new avenues within the rapidly evolving fields of genomics and personalized medicine. This capital infusion is likely to fuel further research and development, enhance product offerings, and potentially expand its global reach, solidifying its role as a key enabler of scientific discovery.
See full DNASTAR company page
